HTLV infection in ELISA-negative blood donors

AIDS Research and Human Retroviruses

Volumn 12, Issue 8, 1996, Pages 737-740

  Zehender, Gianguglielmo ^a,c   Girotto, Mauro ^b   De Maddalena, Chiara ^a   Francisco, Giancarlo ^b   Moroni, Mauro ^a   Galli, Massimo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Ospedale di Ivrea   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INFECTION RATE; INFECTION RISK; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROEPIDEMIOLOGY;

EID: 0029917850     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.737     Document Type: Article

References (16)

1. Blattner WA, Blayney DW, Robert-Guroff M, et al.: Epidemiology of human T-cell leukemia/lymphoma virus. J Infect Dis 1983;147:406-416.
2. Lee H, Swanson P, Shorty VS, Zack JA, Rosenblatt JD, and Chen ISY: High rate of HTLV-II infection in seropositive IV drug abusers in New Orleans. Science 1989;244:471-475.
3. Palumbo PE, Weiss SH, McCreedy BJ, et al.: Evaluation of HTLV infection in a cohort of injecting drug users. J Infect Dis 1992;166:896-899.
4. Gallo D, Penning LM, Diggs JL, and Hanson CV: Sensitivities of radioimmunoprecipitation assay and PCR for detection of human T-lymphotropic type II infection. J Clin Microbiol 1994;32: 2464-2467.
5. World Health Organization: Acquired immunodeficiency syndrome (AIDS): Proposed WHO criteria for interpreting results from Western blot assays for HIV-1, HIV-2, and HTLV-I/HTLV-II. Weekly Epidemiol Rec 1990;37:281-283.
6. Ehrlich GD, Greenberg S, and Abbott MA: Detection of human T-cell lymphoma/leukemia viruses. In: PCR Protocols: A Guide to Methods and Applications (Innis MA, Gelfand DH, Sninsky JJ, and White TJ, eds.). Academic Press, San Diego, California, 1990, pp. 324-336.
7. Wiktor SZ, Alexander SS, Shaw GM, et al.: Distinguishing between HTLV-I and HTLV-II by Western blot. Lancet 1990;335: 1533.
8. Dube S, Spicer T, Bryz-Gornia V, et al.: A rapid and sensitive method of identification of HTLV-II subtypes. J Med Virol 1995;45:1-9.
9. Weiss SH: The evolving epidemiology of human T lymphotropic virus type II. J Infect Dis 1994;169:1080-1083.
10. Hjelle B, Appenzeller O, Mills R, et al.: Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992;339:645.
11. Nishimura M, Mingioli E, McFarlin DE, and Jacobson S: Demonstration of human T-cell lymphotropic virus type I (HTLV-I) from an HTLV-I seronegative South Indian patient with chronic, progressive spastic paraparesis. Ann Neurol 1993;34:867-870.
12. Hjelle B, Wilson C, Cyrus S, et al.: Human T-cell leukemia virus type II infection frequently goes undetected in contemporary US blood donors. Blood 1993;81:1641-1644.
13. Lee HH, Galli C, Brczak JD, et al.: A multicentric seroepidemiological survey of HTLV-I/II in Italy. Clin Diag Virol 1994; 2:139-147.
14. Zehender G, Meroni L, Piconi S, et al.: Frequent detection of antibodies against HTLV antigens in patients with AIDS-related non-Hodgkin lymphoma. AIDS Res Hum Retroviruses 1995;11: 823-827.
15. Korber B, Okayama A, Donnelly R, Tachibana N, and Essex M: Polymerase chain reaction analysis of defective human T-cell leukemia virus type I proviral genomes in leukemic cells with adult T-cell leukemia. J Virol 1991;65:5471.
16. Zella D, Cavicchini A, Salemi M, et al.: Molecular characterization of two isolates of human T cell leukaemia virus type II from Italian drug abusers and comparison of genome structure with other isolates. J Gen Virol 1993;74:437-444.